Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic LeukemiaGila Mostufi-Zadeh-Haghighi(University of Freiburg), Jesús Duque‐Afonso(University of Freiburg)CancersAugust 30, 202310.3390/cancers15174328Cited by 4SaveCiteExport RISWatch citationsRelated PapersDevelopment of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL|Blood Advances|2024|8